168
T. Arai et al. / Tetrahedron: Asymmetry 18 (2007) 165–169
132 mg) in THF (1.5 mL) was added to the mixture. After
being stirred at 60 ꢁC for 8 h, insoluble residue was
removed by filtration, and concentrated in vacuo. The
residue was purified by column chromatography on neutral
silica gel (AcOEt/hexane, 1:15) to give L1b (94.6 mg,
67%) as a solid. Rf 0.28 (AcOEt/hexane = 1:15); 1H
NMR (CDCl3) d: 12.15 (s, 1H), 7.97–7.93 (m, 4H), 7.62
(d, J = 8.2 Hz, 2H), 7.56 (s, 1H), 7.50–7.45 (m, 4H), 7.3–
7.26 (m, 2H), 7.18 (dd, J = 1.5, 7.8 Hz, 1H), 6.89 (dd,
J = 1.6, 7.7 Hz, 1H), 6.74 (t, J = 15.3 Hz, 1H), 4.52 (d,
J = 12.3 Hz, 2H), 3.78 (d, J = 12.3 Hz, 2H), 1.48 (s, 9H);
13C NMR (CDCl3) d: 29.5, 34.9, 56.4, 118.2, 119.4, 125.8,
126.1, 126.6, 127.3, 127.4, 127.7, 128.4, 129.0, 131.4,
132.6, 133.4, 134.8, 136.7, 141.1, 156.7; IR (ATR): 3052,
3008, 2958, 2864, 1495, 752 cmꢀ1; FAB-HRMS calcd for
C33H30N2O 470.2358, found 470.2338.
7.20–7.10 (m, 3H), 7.00 (d, J = 2.5 Hz, 1H), 6.75 (d,
J = 8.7 Hz, 1H), 4.4 (d, J = 12.4 Hz, 2H), 3.7 (d,
J = 12.3 Hz, 2H); 13C NMR (CDCl3) d: 56.5, 110.7,
118.2, 121.3, 126.0, 126.1, 126.7, 127.1, 127.4, 128.4,
129.1, 131.1, 131.4, 131.4, 132.2, 133.3, 134.7, 156.2; IR
(ATR): 3055, 3010, 2924, 2852, 1477, 1267, 754 cmꢀ1
;
FAB-HRMS calcd for C29H21BrN2O (M+) 492.0837,
found 492.0777.
4.6. (R)-3,30-Diformyl-2,20-binaphthol bis-N-(dimethyl-
amino)imine L2a
To a solution of 3,30-diformyl binaphthol (0.3 mmol,
103 mg) in CHCl3 (6 mL) was added 1,1-dimethyl hydra-
zine (2.2 equiv, 51 lL). After being stirred at rt for 16 h,
the reaction mixture was concentrated in vacuo to give
L2a (133.1 mg, 99%) as a yellow solid. Rf 0.25 (AcOEt/hex-
1
4.4. 4-tert-Butyl-2-((E)-((R)-6,7-dihydro-5H-dinaphtho-
[2,1-c;10,20-e]azepin-6-ylimino)methyl)phenol L1c
ane = 1:2); H NMR (CDCl3) d: 11.75 (s, 2H), 7.82–7.76
(m, 4H), 7.66 (s, 2H), 7.28–7.15 (m, 6H), 2.95 (s, 12H);
13C NMR (CDCl3) d: 42.6, 116.6, 121.9, 123.1, 124.7,
126.7, 128.0, 128.2, 129.0, 133.4, 136.8, 152.3; IR (ATR):
3055, 3001, 2956, 2871, 2792, 1435, 750 cmꢀ1; FAB-HRMS
calcd for C26H26O2N4 426.2056, found 426.2021.
To
a mixture of 5-tert-butyl-2-hydroxybenzaldehyde
(0.2 mmol, 34.3 lL) and hydrazine monohydrate (1.0 equiv,
9.7 lL) in ethanol (0.4 mL) was added MgSO4 (2.0 equiv,
48 mg), and the resulting suspension stirred at rt for 2 h.
Then, Et3N (2.0 equiv, 60.2 lL) and 2,20-bromomethyl
binaphthalene (1.0 equiv, 88 mg) in THF (0.4 mL) was
added to the mixture. After being stirred at 60 ꢁC for
26 h, the insoluble residue was removed by filtration, and
concentrated in vacuo. The residue was purified by column
chromatography on neutral silica gel (AcOEt/hexane, 1:15)
to give L1c (42.3 mg, 45%) as a solid. Rf 0.55 (AcOEt/hex-
4.7. (R)-3,30-Diformyl-2,20-binaphthol bis-N-(pyrrolidinyl)-
imine L2b
To a solution of 3,30-diformyl binaphthol (0.23 mmol,
80 mg) in CHCl3 (4 mL) was added 60% aq N-aminopyroli-
zine (4.0 equiv, 150 lL). After being stirred at rt for 6 h, the
reaction was quenched by adding saturated NaHCO3
(30 mL), and the aqueous layer was extracted with CHCl3
(15 mL · 4). The combined extract was dried over Na2SO4.
After removal of the solvent, the residue was purified by
column chromatography on neutral silica gel (AcOEt/hex-
ane, 1:2) to give L2b (110 mg, 99%) as a white solid in yield.
1
ane = 1:4); H NMR (CDCl3) d: 11.48 (s, 1H), 7.95 (dd,
J = 3.5, 8.3 Hz, 4H), 7.60 (d, J = 8.5 Hz, 2H), 7.56 (s,
1H), 7.49–7.45 (m, 4H), 7.30–7.25 (m, 2H), 7.19 (dd,
J = 2.3, 8.6 Hz, 1H), 7.02 (d, J = 2.2 Hz, 1H), 6.90 (d,
J = 8.7 Hz, 1H), 4.50 (d, J = 12.1 Hz, 2H), 3.78 (d,
J = 12.3 Hz, 2H), 1.25 (s, 9H); 13C NMR (CDCl3) d: 31.4,
33.9, 56.6, 116.0, 118.7, 125.8, 125.9, 126.1, 126.3, 127.2,
127.4, 128.4, 129.0, 131.4, 132.6, 133.4, 134.8, 140.6,
1
Rf 0.4 (AcOEt/hexane = 1:2); H NMR (CDCl3) d: 11.69
(s, 2H), 7.79 (d, J = 8.2 Hz, 2H), 7.73 (s, 2H), 7.55 (s,
2H), 7.26–7.15 (m, 6H), 3.33–3.29 (m, 8H), 1.97–1.90 (m,
8H); 13C NMR (CDCl3) d: 23.4, 50.8, 116.5, 122.4, 123.0,
124.7, 126.4, 127.8, 128.2, 128.2, 133.2, 135.7, 152.1; IR
141.7, 155.1; IR (ATR): 3052, 2954, 2870, 1431, 750 cmꢀ1
;
FAB-HRMS calcd for C33H30N2O 470.2358, found
470.2326.
(ATR): 3055, 2958, 2924, 2854, 1435, 1340, 750 cmꢀ1
;
FAB-HRMS calcd for C30H30O2N4 478.2369, found
478.2366.
4.5. 4-Bromo-2-((E)-((R)-6,7-dihydro-5H-dinaphtho-
[2,1-c;10,20-e]azepin-6-ylimino)methyl)phenol L1d
4.8. General procedure for the asymmetric addition of
diethylzinc to benzaldehyde
To a mixture of 5-bromosalicylaldehyde (2 mmol, 402 mg)
and hydrazine monohydrate (1.0 equiv, 97 lL) in THF
(4 mL) was added MgSO4 (5.0 equiv, 600 mg). After being
stirred at rt for 21 h, the insoluble residue was removed by
filtration, and the residue was purified by column chroma-
tography on neutral silica gel (AcOEt/hexane, 1:4) to give
the corresponding hydrazone (97.4 mg, 22% yield). Then,
the hydrazone (0.45 mmol, 97 mg) and Et3N (2 equiv,
135 lL) in THF (1.8 mL) were added to 2,20-bromomethyl
binaphthalene (1.0 equiv, 198 mg). After being stirred at
40 ꢁC for 24 h, the insoluble residue was removed by filtra-
tion, and the residue was purified by column chromatogra-
phy on neutral silica gel (AcOEt/hexane, 1:15) to give L1d
(44.4 mg, 19% yield). Rf 0.3 (AcOEt/hexane = 1:10); 1H
NMR (CDCl3) d: 11.55 (s, 1H), 7.90–7.80 (m, 4H), 7.48
(d, J = 8.5 Hz, 2H), 7.41–7.36 (m, 4H), 7.28 (s, 1H),
To a solution of L2a (17 mg, 0.04 mmol) in anhydrous tol-
uene was added diethylzinc (1.6 mL 1.0 M solution in hex-
ane) under Ar and stirred for 10 min at room temperature.
The solution was cooled at ꢀ20 ꢁC, and benzaldehyde
(81.3 lL, 0.8 mmol) was added slowly. After being stirred
for 6 h at ꢀ20 ꢁC, the reaction was quenched with 1 M
aqueous HCl (20 mL). The mixture was extracted with
Et2O, and the combined organic layer dried over Na2SO4.
After removal of the solvent under reduced pressure, the
residue was purified by column chromatography on silica
gel to afford 1-phenyl-1-propanol (81.7 mg, 75%) as a col-
orless liquid. The enantiomeric excess was determined by
HPLC analysis using a chiral stationary phase column
(Daicel Chiralcel OD, Hex/i-PrOH = 9:1).